Profil
Samuel Menghistu has founded Bloomwell Group GmbH in 2020 and currently holds the title of Director.
Aktive Positionen von Samuel Menghistu
| Unternehmen | Position | Beginn |
|---|---|---|
Bloomwell Group GmbH
 Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | Gründer | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Bloomwell Group GmbH
Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020. | Health Technology |
